Pharmaceutical Executive October 28, 2024
The latest news for pharma industry insiders.
Operating Without a Commercial Blueprint: Empowering the Field for Niche Therapy Launches
How emerging biotech companies can create fruitful partnerships between home office commercial teams and the field force to enable this intelligence gathering, while driving commercial success.
The Dilemma of Childhood Vaccines Post Pandemic
With the end of the PREP Act Provisions in sight, pharmacists should Reflect on their impact and plan to continue them.
Government ‘Guardrails’ for A.I. Tools
A national security memorandum detailed how agencies should streamline operations with artificial intelligence safely.
President Biden has released a series of documents that grapple with the challenges of using A.I. tools to speed up government operations.
LabGenomics USA Completes Acquisition of IMD...